Takeover Price for Lek is Good, says Novartis
Ljubljana, 29 August - The price Novartis has offered in its intent for the takeover of Lek is good, as it is 73 percent higher than its average price in 2002, and 40 percent higher than the share value on 22 August, said Thursday head of Novartis Generics Christian Seiwald. The offer is based on long-term analyses, and the profit for shareholders is high if compared to similar takeovers, noted the official of this Swiss giant.
The rest of this news item is available to subscribers.
The news item consists of 1.758 characters (without spaces) or 361 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.